Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

DTI & Tractography in Pediatric Tumor Surgery

20. juni 2016 opdateret af: Sandrine DeRibaupierre, London Health Sciences Centre

Application of Diffusion Tensor Imaging and Tractography in Pediatric Tumor Surgery

The goal of this project will be to demonstrate that Synaptive Medical's Diffusion Tensor Imaging(DTI) product functionality used in pre-operative planning and intraoperative surgical navigation, improves clinical outcomes corresponding to a reduction in neurological and neuropsychological deficits in pediatric brain tumor surgery.

Studieoversigt

Detaljeret beskrivelse

Brain tumours are the most common form of solid tumours in children which often arise from the cerebellum. Treatment involves a complete resection of the tumour. Although surgical resection may eliminate most of the malignancy, signs of post-neurologic deficit may present as a consequence to the treatment.

One such example is cerebellar mutism syndrome (CMS), a postoperative syndrome typically arising 1 to 2 days after resection of a midline posterior fossa tumor; it consists of diminished speech progressing to mutism, emotional lability, hypotonia, and ataxia. While some of the symptoms recover after a few months, neuropsychological testing shows long term deficits in language (agramatism), executive function and verbal memory.

This study aims to investigate whether the use of Synaptive Medical's BrightMatter™ technology can help neurosurgeons better visualize and plan surgeries by avoiding eloquent fiber tracts in the brain and cerebellum; thus minimizing damage pertaining to neurologic and motor functionality. The use of these products will also be assessed for improved clinical outcomes in pediatric tumor surgery.

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

24

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

Ikke ældre end 18 år (Barn, Voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Pediatric subjects between the ages of 0-18 years with a brain tumor.

Exclusion Criteria:

  • Pediatric subjects with contra-indication to MRI (metal, claustrophobia, etc.)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: Control
Control Group (surgical standard of care): Subjects 18 years and younger diagnosed with a pediatric brain tumor, and who are eligible for surgical treatment will be recruited. All subjects will have clinical MRI scans that include a diffusion tensor imaging (DTI) protocol. Surgery will be carried out according to usual standard of care, without the use of processing for DTI tractography. Additional clinical scanning with the same protocol will be carried out post-operatively at 6 months. Pre-operative and post-operative quality of life assessments, functional testing and clinical outcome tests will be conducted at this post-operative period (6-months).
Andet: Interventional
Interventional Group (involvement of all BrightMatter™ products): Subjects 18 years and younger diagnosed with a pediatric brain tumor and who are eligible for surgical treatment will be recruited. All subjects will have clinical MRI scans that include a diffusion tensor imaging (DTI) protocol and will be sent to the interventional technology (BrightMatter Bridge) for quality control. The QC'ed images will then be sent to a pre-operating planning software (BrightMatter Plan) for planning the surgical approach. Surgery will be carried out with guidance from the exported plan and the intra-operative neuro-navigation software, BrightMatter Guide, with the use of post-processing DTI tractography. Additional clinical scanning with the same protocol will be carried out post-operatively at 6 months. Pre-operative and post-operative quality of life assessments, functional testing and clinical outcome tests will be conducted at this post-operative period (6-months).

BrightMatter™ Plan (BMP): BMP er en software, der gør det muligt for kirurger at planlægge deres neurokirurgi præoperativt. BMP genererer automatisk helhjernetraktografi og meget nøjagtig sammensmeltning af anatomiske MR- og DTI-billeder.

BrightMatter™ Bridge (BMB): BMB involverer at tilbyde SMI's MRI-ekspertise for at sikre en jævn arbejdsgang inden for neuroimaging inklusive DTI for at sikre, at optimerede protokoller bruges til at erhverve DTI-billederne. Når billederne er erhvervet, evalueres de for deres kvalitet i realtid ved hjælp af en kvalitetskontrol (QC) algoritme. QC tillader kvalitetsvurdering af DTI-billeder på scanningstidspunktet, hvilket giver mulighed for øjeblikkelig korrektion, mens patienten stadig er der, og reducerer behovet for genscanning af patienten.

BrightMatter™ Guide (BMG): BMG er et neuro-navigationssystem, der bruger DTI-informationen og den bane, som kirurgen i BMP har planlagt præoperativt, men som bringer den ind på operationsstuen intraoperativt.

Andre navne:
  • BrightMatter™ Plan, BrightMatter™ Bridge, BrightMatter™ Guide

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Total volume of tract damage
Tidsramme: Assess the total volume of tract damage from baseline pre-operative examination through study completion (~ 1 year).
Measure # of damaged tracts
Assess the total volume of tract damage from baseline pre-operative examination through study completion (~ 1 year).
Total size of craniotomy (resection zone)
Tidsramme: Measure the total size of craniotomy from time of incision to end of surgery. (1 measurement/subject).
Measure craniotomy size
Measure the total size of craniotomy from time of incision to end of surgery. (1 measurement/subject).

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Total time it takes for the surgeon to pre-operatively plan cranial approach.
Tidsramme: Assessed during start of surgical pre-operative plan through to end of surgical pre-operative plan (1 measurement/subject).
Measured in hours
Assessed during start of surgical pre-operative plan through to end of surgical pre-operative plan (1 measurement/subject).
Samlet ELLER-tid
Tidsramme: Vurderet under kirurgisk besøg
Målt i timer
Vurderet under kirurgisk besøg
Duration of hospital stay
Tidsramme: Assessed during surgical visit up to 26 weeks
Measured in # of days
Assessed during surgical visit up to 26 weeks
Total cost of surgery
Tidsramme: Assessed through study completion, an average of 1 year
Assessed through study completion, an average of 1 year
Quality of life assessment
Tidsramme: Assessed during surgical visit up to 26 weeks
Measured using a standard questionnaire known as the WHOQOL-BREF questionnaire-World Health Organization Quality of Life Assessment
Assessed during surgical visit up to 26 weeks
Functional testing
Tidsramme: Assessed during surgical visit up to 26 weeks
Measured using a routine functional impairment test for the pediatric population known as the Lansky performance scale
Assessed during surgical visit up to 26 weeks
# deaths and complications with surgery
Tidsramme: Assessed post-operatively after each surgery. Patient is followed until study completion (~ 1 year).
Number of cases
Assessed post-operatively after each surgery. Patient is followed until study completion (~ 1 year).

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juli 2016

Primær færdiggørelse (Forventet)

1. juli 2017

Studieafslutning (Forventet)

1. juli 2017

Datoer for studieregistrering

Først indsendt

18. marts 2016

Først indsendt, der opfyldte QC-kriterier

20. juni 2016

Først opslået (Skøn)

23. juni 2016

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

23. juni 2016

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. juni 2016

Sidst verificeret

1. juni 2016

Mere information

Begreber relateret til denne undersøgelse

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner